Immune system study for ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how the immune system works in people with epithelial ovarian cancer. It aims to understand the immune landscape around the tumor, which could lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a suspected or confirmed diagnosis of epithelial ovarian cancer.
- You must be scheduled for surgery to treat your ovarian cancer or a recurrence.
- You must be able to perform daily activities with minimal assistance (ECOG score of 0–2).
- You cannot have another active cancer that might affect the study results.
- You cannot have an active autoimmune disease or be on long-term steroids or immune-suppressing medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune-related markers in people with ovarian cancer to see if they can help predict prognosis (how the cancer may behave). If you qualify, your doctors may use your immune test results alongside other standard treatments like surgery, chemotherapy, and/or immunotherapy.
This study looks at how changes in your immune system's T-cells (measured from blood samples) can help predict if ovarian cancer comes back. If you are newly diagnosed with advanced ovarian cancer and planning standard treatments (surgery plus chemo), you may join.
This trial tests a personalized vaccine for people with epithelial ovarian cancer who still have a small amount of cancer DNA in their blood after surgery. The goal is to see if the vaccine can help stop the cancer from coming back.
This study uses whole-body scans to look at how active tumors are in women with suspected ovarian cancer. The goal is to see if these scans can predict how well treatment will work, which may help personalize care.
This study looks back at different surgical methods (open or minimally invasive) used for early-stage epithelial ovarian cancer. It aims to compare outcomes and help doctors choose the best approach.
This study looks at how your immune system behaves around the time of planned surgery for certain breast or ovarian cancers. It may help researchers understand what immune changes happen and how they relate to your cancer.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.